motixafortide – Patient Worthy

Source: Pixabay.com

GENESIS Trial: Motixafortide And G-SCF Prepared Multiple Myeloma Patients for Transplant

Post author:Rose Duesterwald
Post published:February 3, 2022
Post category:Multiple Myeloma

It is common practice to treat multiple myeloma patients with a stem cell transplant. In the GENESIS trial, the stem cells were autologous (from the patient’s own peripheral blood or bone…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More